Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-05-09
2006-05-09
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S453000
Reexamination Certificate
active
07041695
ABSTRACT:
The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of a CNS disorder relating to or affected by the 5-HT6 receptor
REFERENCES:
patent: 6528653 (2003-03-01), Gill et al.
patent: 6730694 (2004-05-01), Beight et al.
patent: 1219603 (2002-07-01), None
patent: WO 2004/018479 (2004-03-01), None
patent: WO 2004/018480 (2004-03-01), None
patent: WO 2004/018480 (2004-04-01), None
Riemer, et al., “Influence of the 5-HT6 Receptor on Acetylcholine Release in the Cortex: Pharmacological Characterization of 4-(2-Bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine, . . . ,” J. Med. Chem. vol. 46, 1273-1276 (2003).
David-Wensbo et al.,Tetrahedron Letters, 1995, vol. 51, No. 37, 10323-10342.
Joseph B. Blair et al.,Journal of Medicinal Chemistry, 1999, vol. 42, No. 6, 1106-1111.
Freistein Andrew B.
Lences Barbara L.
Saeed Kamal A.
Wyeth
LandOfFree
N-sulfonylheterocyclopyrrolyl-alkylamine compounds as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-sulfonylheterocyclopyrrolyl-alkylamine compounds as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-sulfonylheterocyclopyrrolyl-alkylamine compounds as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3618295